Aurobindo Pharma Limited (NSEI: AUROPHARMA)
Health Care · Pharmaceuticals · IN
Rs1,676.80
-2.06% today · +53.4% 1Y
Aurobindo Pharma Limited (NSEI: AUROPHARMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $10.02B and employs 29,209 people.
Over the last twelve months the share price has gained 53.4%, trading between 1.07K and 1.74K.
Tweenvest scores Aurobindo Pharma Limited across four factors: quality 81/100, value 23/100, growth 54/100, dividend 14/100. Its strongest factor is quality.
AUROPHARMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.02B
- Revenue (TTM)
- $3.69B
- P/E
- 26.20
- EPS
- 63.99
- Dividend yield
- 0.48%
- Beta (5Y)
- 0.03
- 52-week high
- Rs1,740.00
- 52-week low
- Rs1,066.80
- Avg volume (3M)
- —
- Shares outstanding
- 575.38M
- Employees
- 29,209
- Next earnings
- —
About Aurobindo Pharma Limited
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
- ISIN
- INE406A01037
- Founded
- 1986
- Listed since
- Jan 15, 1996
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Mankind Pharma LimitedNSEI: MANKIND | $10.87B | Rs2,535.00 | +2.43% |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.SHSE: 600436 | $10.61B | CN¥118.00 | +2.41% |
| Dr. Reddy's Laboratories LimitedBSE: 500124 | $10.35B | Rs1,202.40 | -0.56% |
| Haisco Pharmaceutical Group Co., Ltd.SZSE: 002653 | $10.28B | CN¥62.18 | +1.42% |
| Asymchem Laboratories (Tianjin) Co., Ltd.SZSE: 002821 | $9.93B | CN¥188.62 | +5.79% |
| CSPC Innovation Pharmaceutical Co., Ltd.SZSE: 300765 | $9.80B | CN¥47.19 | +6.89% |
| Sichuan Kelun Pharmaceutical Co., Ltd.SZSE: 002422 | $9.69B | CN¥40.85 | +5.12% |
| Lupin LimitedBSE: 500257 | $9.64B | Rs2,029.00 | -2.92% |
Figures last refreshed Oct 4, 2026.